-
MISSION
To Improve the Health of People
with High-quality Medical Services -
VISION
To Become a World-class
Medical Center -
CORE VALUES
To Seek Truth with Prudence
To Be Practical-minded
Founded in 1947, The First Affiliated Hospital, Zhejiang University School of Medicine (FAHZU), is the earliest affiliated hospital of Zhejiang University. Today, it is a large, modern, top-tier tertiary general hospital that integrates medical care, education, and research. FAHZU is building a National Medical Center, a National Pilot Unit for the High-quality Development of Public Hospitals, a National Medical Center for Infectious Diseases, and a Leading Institution to Build a National-level Comprehensive Regional Medical Center.
FAHZU spans a total area of approximately 519.3 mu (about 34.6 hectares) and offers almost 5,000 inpatient beds. The year 2024 has witnessed over 9.38 million outpatient and emergency visits with 395,000 inpatient discharges.
In March 2025, the National Health Commission of China released the performance evaluation results for tertiary public hospitals for the year 2023. Among 1,588 tertiary general public hospitals assessed nationwide, FAHZU was rated A++ for the sixth consecutive year, placing it in the top 1% nationwide.
In July 2024, the Chinese Academy of Medical Sciences published the 2023 China Hospital Science and Technology Evaluation Metrics (STEM) report. FAHZU ranked 6th nationwide in overall scientific and technological strength, with eight specialties ranked among the national top ten. Notably, Infectious Diseases and Gastroenterology both secured first place nationwide. Over the past five years, FAHZU ranked 5th in total STEM value across all hospitals in China.
FAHZU is designated as a National Talent Training Base by the Ministry of Science and Technology and serves as a National Model Base for Talent Recruitment and International Cooperation. The hospital currently employs over 11,000 staff, including 544 with senior titles and 860 with associate senior titles. There is a galaxy of talents, namely, 2 academicians of the Chinese Academy of Engineering, 10 Experts from national-level major talent recruitment programs, 5 Changjiang Scholars (Distinguished Professors) appointed by the Ministry of Education, National Science Fund for Distinguished Young Scholars (NSFC Outstanding Youth) recipients, 7 Leading Talents from the National Ten Thousand Talents Program, 20 National Outstanding Young Talents, 3 Distinguished Experts of Zhejiang Province and 36 “Qiushi Distinguished Scholars” of Zhejiang University.
FAHZU is rapidly emerging as a national leader in advanced medical disciplines. The hospital currently holds 2 national key disciplines and 28 national clinical key specialties (including 6 under development). It enjoys a strong reputation in fields such as organ transplantation, infectious diseases, hematological diseases, nephrology, urological diseases, and clinical pharmacy. It is recognized as one of the most comprehensive medical centers in China for major organ transplantation. It leads several major national research center platforms and serves as a national treatment base for major infectious diseases and plays a leading role in the national program to enhance the diagnosis and treatment of complex diseases, particularly in the field of critical care medicine.
FAHZU boasts a strong foundation in scientific research, with a total research facility area of 54,500 square meters and 1,226 full-time research staff. The hospital has undertaken numerous national-level research projects, including the National Major Science and Technology Projects, the National Key R&D Programs, and grants from the National Natural Science Foundation of China (NSFC). To date, it has led 57 research projects with funding exceeding 10 million RMB each, and in the past five years alone, FAHZU has been awarded 759 NSFC grants, with annual research funding exceeding 300 million RMB for five consecutive years.
FAHZU has achieved remarkable recognition in scientific advancement, including 1 Grand Prize of the State Science and Technology Progress Award – the only such award ever granted to an institution in the education or healthcare system since the founding of the People's Republic of China, 2 First Prizes and 9 Second Prizes of the State Science and Technology Progress Award.
Over 40 First Prizes for scientific and technological advancement from the Ministry of Education, Chinese Medical Association, Zhejiang Province, and other authoritative institutions
The hospital has published over 600 high-impact scientific papers, including works where FAHZU served as the first corresponding author or leading institution in top-tier journals such as Nature, Cell, Science, The New England Journal of Medicine (NEJM), and The Lancet. The total number of indexed publications across the three major citation databases has continued to rise year over year, and FAHZU has been featured in the “National Ranking of Outstanding Scientific Publications by Medical Institutions”.
To date, the hospital holds over 1,000 authorized patents and has published more than 200 academic monographs.
FAHZU offers a full spectrum of medical education programs, including undergraduate and postgraduate training, standardized residency and specialist physician training, and continuing medical education. It is among the first National Clinical Teaching and Training Demonstration Centers, the National Demonstration Base for Standardized Residency Training, the first National Practical Teaching Bases for the "Grand Ideological and Political Course" Initiative, and the first National Training Bases for Basic Surgical Skills Enhancement and
the founding member of China Elite Teaching Hospital Alliance. In the first national evaluation of clinical practice education quality among university-affiliated hospitals, FAHZU ranked 10th nationwide and 1st in Zhejiang Province.
It has 1 National Teaching Team, 2 National-Level Excellent Resource Sharing Courses, 1 National-level High-Quality Open Video Course, 4 National-Level Forst-Class Courses and 59 nationally designated textbooks edited or co-edited by FAHZU faculty. Faculty resources include 202 doctoral supervisors and 490 master’s supervisors. The hospital also hosts 23 National Residency Training Bases (including 6 key specialty bases), 8 National Specialist Physician Training Pilot Bases, 2 National Continuing Medical Education Bases, 2 Advanced Training Centers for Surgeons, jointly accredited by the Royal College of Surgeons of Edinburgh and the College of Surgeons of Hong Kong.
FAHZU has long been committed to fostering international collaboration and global engagement. It has established multi-level partnerships with over 50 world-leading institutions, including Johns Hopkins Hospital and the University of Pittsburgh Medical Center in the United States.
The hospital is home to several high-level international cooperation platforms, including, the China-Arab Public Health Science and Technology Cooperation Center (Ministry of Science and Technology) and the Joint International Laboratory for Pancreatic Diseases (Ministry of Education).
FAHZU was honored as an Outstanding Collective in Zhejiang Province for its contributions to the Belt and Road Initiative.
The hospital places strong emphasis on the international training of medical professionals. It is the only institution in China accredited as a training base for general surgery attending physicians by Johns Hopkins University, attracting a growing number of international medical professionals for study and exchange.
In addition, FAHZU led the establishment of China’s first provincial-level committee for foreign affairs in the healthcare sector—the Foreign Affairs Committee of the Zhejiang Hospital Association—and serves as the chair institution. This initiative aims to build a model platform for international healthcare cooperation at the provincial level.
The hospital is also actively advancing international medical services and was recognized as one of the first batch of Internationalized Hospitals in Hangzhou.
In addition, FAHZU initiated the “Little Yellow Man” Charity Program, which has provided life-saving assistance to over 1,000 children with end-stage liver disease, with more than 160 million RMB invested in total charitable support. The program was named “Charity Project of the Year” in the 19th China Philanthropy List (2022) and Zhejiang Charity Award (2025), setting a powerful example of how cutting-edge medical technology can be channeled into public welfare and humanitarian care.
FAHZU is at the forefront of digital hospital innovation, driven by a comprehensive system architecture known as “Feitian”, which integrates one cloud, one network, and one system. Leveraging big data analytics and artificial intelligence, digital technologies are deeply embedded across all aspects of hospital management, from clinical services and health management to performance optimization.
The hospital has deployed an integrated “smart brain + intelligent management” system across its multiple campuses, enabling real-time operational data analysis to support high-level management decisions.
FAHZU has also developed a next-generation “Future Hospital” Electronic Medical Record (EMR) system, built on an innovative architecture and enhanced by knowledge graph learning to improve medical record quality control and standardize clinical practice.
In diagnostics, FAHZU has created AI-assisted platforms for ultrasound, CT, and pathology imaging interpretation, currently deployed across 117 county-level medical consortia throughout Zhejiang Province, greatly improving diagnostic efficiency and accessibility.
Additionally, the hospital launched an advanced logistics system capable of intelligent route and time planning to streamline the transport of bulk medical supplies within inpatient departments.
FAHZU’s “Smart Multi-Campus Hospital Application” was recognized as one of the Best Digital Reform Applications of Zhejiang Province in 2022, highlighting its role as a benchmark in healthcare digital transformation.
